Principal Financial Group’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.25M	Buy	258,684 +6,109	+2%	+$200K	﹤0.01%	1487
2025 Q4	$9.45M	Buy	252,575 +21,646	+9%	+$712K	﹤0.01%	1342
2025 Q3	$6.36M	Buy	230,929 +319	+0.1%	+$11K	﹤0.01%	1499
2025 Q2	$7.29M	Buy	230,610 +17,194	+8%	+$553K	﹤0.01%	1408
2025 Q1	$7.08M	Buy	213,416 +4,753	+2%	+$170K	﹤0.01%	1425
2024 Q4	$7.18M	Buy	208,663 +46,194	+28%	+$1.59M	﹤0.01%	1450
2024 Q3	$6.5M	Sell	162,469 -19,654	-11%	-$690K	﹤0.01%	1473
2024 Q2	$5.49M	Sell	182,123 -9,927	-5%	-$298K	﹤0.01%	1527
2024 Q1	$6.45M	Sell	192,050 -5,994	-3%	-$192K	﹤0.01%	1489
2023 Q4	$6.4M	Sell	198,044 -1,706	-0.9%	-$47.6K	﹤0.01%	1477
2023 Q3	$6.55M	Buy	199,750 +16,260	+9%	+$564K	﹤0.01%	1427
2023 Q2	$6.46M	Sell	183,490 -3,173	-2%	-$110K	﹤0.01%	1437
2023 Q1	$6.09M	Sell	186,663 -5,691	-3%	-$259K	﹤0.01%	1468
2022 Q4	$10.6M	Sell	192,354 -5,622	-3%	-$309K	0.01%	1213
2022 Q3	$8.77M	Buy	197,976 +7,145	+4%	+$349K	0.01%	1259
2022 Q2	$9.31M	Sell	190,831 -4,907	-3%	-$221K	0.01%	1298
2022 Q1	$9.52M	Buy	195,738 +37,181	+23%	+$1.52M	0.01%	1403
2021 Q4	$6.76M	Buy	+158,557	New	+$6.32M	﹤0.01%	1562